The Bleeding continueshttps://www.science.org/content/article/second-death-linked-potential-antibody-treatment-alzheimer-s-disease
Just a day before they are suppposed to present their data at the clinical trials conference , another potential death that could be attributed to brain bleeding, this time the severe reaction with a anti-clotting medicine.
I am sure this is going to be on everyones mind and it will be very very interesting to see the questions and comments /opinions of experts after this presentation. Big question " will it impact how the FDA looks at the fast track approval for this porduct "
If you examine this report , that same thing jumps out at you " this company is trying to remove the amyloid plaque from the brain"
This could have a very positive outlook for companies like PMN that are dealing with the misfolded oligomer and ignoring the plaque as the main culprit in AD.